← All trials
NCT01849341
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2012
- Primary completion
- Dec 1, 2013
- Completion date
- Jul 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 105
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Government of SpainLead sponsor
- Complejo Hospitalario de Especialidades Juan Ramón JimenezOverall official - principal investigator
- Hospital de JerezOverall official - principal investigator
- H.U. Virgen de las NievesOverall official - principal investigator
- Complejo Hospitalario Carlos HayaOverall official - principal investigator
- HAR de LojaOverall official - principal investigator
- Hospital Infanta ElenaOverall official - principal investigator
- Hospital Universitario Puerto RealOverall official - principal investigator
- Hospital Universitario Virgen MacarenaStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.